Skip to main content

Table 1 Demographic and clinical data of the three study populations.

From: BACE-1, PS-1 and sAPPβ Levels Are Increased in Plasma from Sporadic Inclusion Body Myositis Patients: Surrogate Biomarkers among Inflammatory Myopathies

 

Sporadic inclusion body myositis (n = 21)

Controls (n = 20)

Dermatomyositis and polymyositis (n = 14)

Statistical significance

Demographic data

    

Male [n (%)]

10 (47.6)

13 (65)

6 (43)

NS

Female [n (%)]

11 (52.3)

7 (35)

8 (57)

NS

Age (years) (mean ± SEM)

67.7 ± 2.3

68.5 ± 1.4

59.3 ± 2.8

NS

Disease progression data

    

IBMFRS test

23.6 ± 1.66

-

-

-

  1. NS, nonsignificant; SEM, standard error of the mean. The IBMFRS is a disease-specific, 10-point functional rating scale for patients with sIBM. This test classifies the clinical features of sIBM (with a maximum score of 40) according to the impossibility to perform daily activities such as dressing, personal hygiene and swallowing (0 score).